Navigation Links
Spike in testicular cancer is focus

Pinpointing reasons behind the dramatic increase in testicular cancer, now the most common malignant cancer among 15-to-35-year-old Caucasian men, is the focus of a five-year, $5.5 million National Cancer Institute (NCI) grant to Yale Public Health researcher Tongzhang Zheng.

Testicular cancer is increasing for unknown reasons and this study will provide important information on possible environmental, genetic and other risk factors,?said Zheng, professor and head of the Division of Environmental Health Sciences in the Department of Epidemiology and Public Health at Yale School of Medicine.

Zheng will collaborate with researchers at Harvard School of Public Health and the Fred Hutchinson Cancer Research Center to conduct a population-based, case-control study on men in Connecticut and Massachusetts. The researchers will determine whether exposure to environmental factors such as environmental hormone disruptors increases the risk of testicular cancer. They will measure the levels of these environmental compounds in 800 patients with testicular cancer and in an equal number of unaffected control subjects.

Because so little is known about the potential environmental causes of testicular cancer, Zheng said, the team will collect and evaluate information on various major suspected risk factors, such as past medical history, history of hernia, venereal diseases, and any medication with androgens and other hormones. They will also examine lifetime occupational history, tobacco smoking, alcohol consumption and dietary information.

“Recent studies show that environmental exposures may affect development of testicular cancer,?said Zheng. “Determining risk factors that lead to testicular cancer, however is complicated because genetic susceptibility may modify a person’s risk from environmental exposures. We will try to assess the potential gene environment interaction on the manifestations of the disease.?


'"/>

Source:Yale University


Page: 1

Related biology news :

1. Study hints at role of stem cell genes in testicular, breast cancers
2. Viral DNA sequence a possible trigger for breast cancer
3. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
4. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
5. Columbia research lifts major hurdle to gene therapy for cancer
6. Combination therapy boosts effectiveness of telomere-directed cancer cell death
7. Mitochondrial DNA mutations play significant role in prostate cancer
8. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
9. BRCA1 causes ovarian cancer through indirect, biochemical route
10. Researchers identify target for cancer drugs
11. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
(Date:2/15/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... drastically boosts productivity with single click reliable nanoscale images, is now available on Park ... and taking the image once done manually by the operator producing high quality nanoscale ...
(Date:2/15/2017)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced ... and full year ended December 31, 2016. ... as we continued to demonstrate strong growth in ... Fanapt," said Mihael H. Polymeropoulos, M.D., Vanda,s President ... important 2017 milestones underscores Vanda,s commitment to bringing ...
(Date:2/15/2017)... ... February 15, 2017 , ... ... hold its sixth annual open house and technology show, Morris Madness, March 14-15, ... metal cutting demos from Okuma, Tsugami and Hardinge Group in addition to displays ...
Breaking Biology Technology: